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Abstract
Background: Valvular heart diseases and mainly rheumatic heart diseases complicate about 1% of pregnancies. During pregnancy 
physiological hemodynamic changes of the circulation are the main cause of mitral stenosis (MS) decompensation. Prior to introduction 
of percutaneous mitral balloon commissuroplasty (PTMC), surgical comissurotomy was the preferred method of treatment in patients 
with refractory symptoms. PTMC is an established non-surgical treatment of rheumatic mitral stenosis. The study aimed to assess the 
safety and efficacy of PTMC in pregnant women with severs mitral stenosis.
Material and Method: Thirty three consecutive patients undergoing PTMC during pregnancy enrolled in this prospective study. Mitral 
valve area (MVA), transmitral valve gradient (MVG), and severity of mitral regurgitation (MR) were assessed before and 24 hour after 
the procedure by transthoracic and transesophageal echocardiography. Mitral valve morphology was evaluated before the procedure 
using Wilkin’s criteria. Patient followed for one month and neonates monitored for weight and height and adverse effect of radiation.
Result: Mitral valve area increased from 0.83 ± 0.13 cm² to 1.38 ± 0.29 cm² (P = 0.007). Mean gradient of mitral valve decreased 
from 15.5 ± 7.4 mmHg to 2.3 ± 2.3 mmHg (P = ,0.001). Pulmonary artery pressure decreased from 65.24 ± 17.9 to 50.45 ± 15.33 
(P = 0.012). No maternal death, abortion, intrauterine growth restriction was observed and only one stillbirth occurred.
Conclusion: PTMC in pregnant women has favorable outcome and no harmful effect on children noted.
Keywords: percutaneous transluminal mitral commissurotomy (PTMC), mitral stenosis (MS), pregnancyAbdi et al
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measured before and 24 hours after the procedure 
by means of two-  dimensional and   transesophageal 
  echocardiography  to  evaluate  the  efficacy  of  the 
procedure.    Transthoracic    echocardiography  was 
  performed with a General Electric Vivid 3 machine 
with  a  2.5-MHz  probe,  and  images  obtained  in 
parasternal long and short axis and apical two- and 
four-chamber views. Mitral valve area, mean trans-
mitral gradient, and severity of mitral regurgitation 
were assessed before the   procedure, 24 hr after it, and 
during long-term   follow-up. Mitral valve morphol-
ogy was also evaluated before the procedure using 
Table 1. Baseline characteristics of study population.
Mean maternal weight (kg) 60.55
Mean maternal height (cm) 158.12
Mean age (year) 31.55 ± 6.3
Mean gestational age (weeks) 21.85 ± 5.8
Function class (n)
  nYhA class I 
  nYhA class II 
  nYhA class III 
  nYhA class IV
1 
11 
19 
2
Mitral regurgitation
  none 
  Mild 
  Moderate
15 
17 
1
echocardiographic mitral valve  
score before PTMC
  ,8 
  9–10 
  .10
15 
17 
1
Left atrial thrombus
  Yes 
  no
0 
33
Left atrial appendage thrombus
  Yes 
  no
2 
31
rhythm
  normal sinus rhythm 
  Atrial fibrillation
30 
3
Previous valvular disease
  Yes 
  no
23 
10
Previous invasive procedure
  Yes 
  no
10 
23
Type of previous procedure
  PTMC 
  CMVC 
  OMVC + PTMC
8 
1 
1
Mean gestational age at valvotomy 22 ± 5.8
Abbreviations: nYhA, new York heart Association; CMVC, closed mitral 
valve commissurotomy; OMVC, open mitral valve commissurotomy.
Introduction
Valvular heart diseases complicate 0.5 to 1.5 percent 
of all pregnancies.1 Mitral stenosis is the most com-
mon  form  with  increased  pregnancy  and  delivery 
complications for both mother and neonate.2 During 
pregnancy  physiological  hemodynamic  changes  of 
the circulation are the main cause of mitral stenosis 
deco  mpensation.3  The  symptoms  are  poorly  toler-
ated especially beyond second trimester and in other 
cases may lead to frank heart failure.4,5 Most pregnant 
women with mitral stenosis can be adequately treated 
with  medical  therapy  and  sometimes  an  invasive 
procedure  is  mandatory.6–9  Before  the  introduction 
of percutaneous transluminal mitral comissurotomy 
(PTMC) surgical comissurotomy was the sole answer 
to pregnant women with refractory symptoms. The 
high  mortality  rate  (1.8%  to  33%)  of  surgery  and 
favorable outcome of PTMC in relieving symptoms 
plus  lower  risk  of  fetal  death  made  PTMC  more 
popular.10–15  Prospective  studies  on  PTMC  and  its 
effect on pregnancy outcome and neonate are needed. 
In this study we aimed to investigate the clinical out-
come of pregnant women undergoing PTMC and to 
assess the neonate condition after one month.
Material and Methods
A consecutive series of thirty three pregnant women 
undergoing  PTMC  in  Rajaei  Heart  Center  from 
March 2004 to March 2009 enrolled in this prospec-
tive descriptive study. The study was approved by 
ethical committee of Rajaei Cardiovascular Medical 
and Research Center.
Patients with severe mitral stenosis and follow-
ing criteria were scheduled for invasive intervention: 
Progressive symptoms during first trimester in spite 
of adequate medical therapy, severe   hemoptysis, and 
history of acute pulmonary edema during pregnancy.
Excluding criteria were severe mitral regurgita-
tion and left atrial thrombus. PTMC was performed 
using Inoue balloon. Balloon diameters were chosen 
according to the patient’s body surface. Lead shields 
were used to protect the abdomen during the proce-
dure limiting fetal radiation exposure. Fluoroscopy 
time was measured during the procedure. Heparin 
(80 IU/kg,   intravenously) was administered twice dur-
ing the procedure. Mitral valve area, transmitral valve 
gradient  and  severity  of  mitral  regurgitation  were   Immediate results of PTMC in pregnant women with mitral stenosis
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Table 2. Clinical data of patients.
Index pre-procedure post-procedure P value
Mitral valve area 0.83 ± 0.14 1.39 ± 0.29 0.007
Pulmonary artery pressure 65.24 ± 17.9 50.45 ± 15.33 0.012
Left ventricular ejection fraction 51.97 ± 5.99 51.82 ± 5.7
Left atrial pressure 28.3 ± 7.2 15 ± 5.45 0.01
Left ventricular end diastolic pressure 12.33 ± 4.9 12.64 ± 4.74
Mitral valve gradient 15.55 ± 7.41 2.36 ± 2.36 0.001.
Table 3. Changes in functional capacity (nYhA) after PTMC.
Function capacity 0 I II III IV P value
Before PTMC – 1 (3%) 11 (33.3%) 19 (57.6%) 2 (6.1%) ,0.001
After PTMC 17 (51.5%) 15 (45.5%) 1 (3%) – –
criteria  by  Wilkins  et  al.16  Mitral  valve  velocities 
were  assessed  with  continuous-wave    Doppler  and 
mitral valve area was estimated from the   Doppler 
pressure  half-time    method.17  Mitral    regurgitation 
was  graded  as  mild,  moderate,  or  severe  accord-
ing to jet length and area by two independent obse-
rvers.   Clinical follow-up after hospital discharge was 
accomplished by medical visits one month after dis-
charge and was continued to the next year at the three 
months   intervals. Finally patients were   scheduled to 
be visited every 6 months for life time. Moreover, 
all babies were examined after delivery for any mal-
formation and their development was assessed after 
one month. Continuous variables are expressed in 
mean ± SD. Comparison between the groups was 
accomplished by Student’s two-tailed test. A P value 
of 0.05 was considered of statistical significance.
Results
Demographic data are summarized in Table 1. Mean 
maternal age was 31.55 ± 6.3 years and mean ges-
tational  age  was  21.85  ±  5.8  weeks.  PTMC  was 
performed successfully in all patients. After the pro-
cedure, mean MVA increased from 0.83 ± 0.13 cm² 
to 1.38 ± 0.29 cm² (P-value ,0.001). Mean MVG 
significantly  decreased  from  15.5  ±  7.4  mmHg  to 
2.3  ±  2.3  mmHg  (P-value  ,0.001).  Also  a  sig-
nificant decrease in pulmonary artery pressure was 
detected  from  65  ±  18  mmHg  to  50  ±  15  mmHg 
(P = 0.012). Mean left atrial pressure decreased sig-
nificantly from 28.3 ± 7.2 to 15 ± 5.45. No significant 
change occurred in left ventricular ejection fraction 
and left ventricular end diastolic volume before and 
after procedure (Table 2). Symptoms of heart failure 
improved in all patients, and none of them experi-
enced NYHA class III or IV (Table 3). Mitral regurgi-
tation in six patients changed from mild to moderate 
and in one case to severe after procedure (Table 4). 
No maternal death, abortion, or intrauterine growth 
retardation was reported. There was one case with 
stillbirth and four neonates with respiratory distress. 
Infants assessed after one month by pediatrics and all 
had normal growth and development.
Discussion
Pregnancy is characterized by a hyper dynamic state 
with significant change of hemodynamic especially 
between the 24th and 26th week of gestation and can 
explain  decompensation  in  pregnant  women  with 
critical  mitral  stenosis.1,3  However,  most  patients 
respond well to adequate medical therapy. In some 
cases, maximal clinical therapy is not enough and 
an invasive intervention is required. Surgical mitral 
commissurotomy was performed during pregnancy 
with precautions mainly due to the high mortality 
rates of mother and neonates.15–17 Percutaneous mitral 
valvuloplasty was first performed in 1984. PTMC 
proved  a  safe  procedure  with  outstanding  results. 
  However,  studies  with  proper  follow-up  have  not 
yet been fully described. The present study shows an 
excellent outcome for the patients after PTMC. After 
the successful procedure, all of the patients were in Abdi et al
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Table 4. Changes in mitral regurgitation produced by PTMC (by echocardiography).
Mitral regurgitation non Mild Moderate severe P value
Before PTMC 15 (45.5%) 17 (51.5%) 1 (3%) – 0.005
After PTMC 12 (36.4%) 13 (39.4%) 7 (21.2%) 1 (3%)
FC I or II and none of them required an additional 
surgical  procedure  until  the  end  of  pregnancy.  In 
addition, there were no deaths related to the proce-
dure.   Echocardiographic examinations also showed 
  favorable results, with a significant increase in mitral 
valve  area  and  decrease  in  transmitral  gradient 
shortly after the procedure. Only one case of severe 
mitral regurgitation was observed.
The excellent results observed after PTMC in this 
study can be attributed to the young age of the group 
and suitable mitral valve morphology. These param-
eters are both important predictors of short and long 
term results.16,18
There  were  neither  maternal  nor  fetal  deaths 
directly related to the procedure. No fetal abnormali-
ties were found during examination and no clinical 
abnormalities  could  be  associated  with  the  use  of 
ra  diation. C  oncerning the radiation exposure, the max-
imum safe radiation dose for the mother and the child 
has been established as 5 rads. Similar fl  uoroscopy 
time and the same protection used in other series, 
reported the total amount of received radiation to be 
approximately 0.5 rads, therefore far below the estab-
lished limit.
In summary, due to the favorable results observed, 
percutaneous mitral valvuloplasty can be considered 
the procedure of choice to treat pregnant women with 
mitral  stenosis  unresponsive  to  adequate  medical 
therapy.
conclusion
The present study shows an excellent outcome for the 
patients after PTMC with no clinical abnormalities 
associated to the use of radiation in neonates.
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